申请人:Eli Lilly and Company
公开号:US08263772B2
公开(公告)日:2012-09-11
The present invention relates to a melanin concentrating hormone antagonist compound of formula (1): wherein R1, Ra, Rb, R2, L1, R3, R4 and R5 are as defined, or a pharmaceutically acceptable salt, enantiomer, diastereomer or mixture of diasteromers thereof useful in the treatment, obesity and related diseases.
本发明涉及一种公式(1)的黑色素浓缩激素拮抗剂化合物:其中R1、Ra、Rb、R2、L1、R3、R4和R5如定义所述,或其药学上可接受的盐、对映体、非对映体或其混合物,用于治疗肥胖和相关疾病。